Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Enokida

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Japanese Journal of Clinical Oncology|April 30, 2026
Impact of treatment volume on outcomes for patients with penile cancer at relatively low-volume centers in JapanYoji Murakami, Takahiro Yamaguchi, Masato Goya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 11, 2025
Penile Cancer: Differences Between Patients Over and Under the Age of 75 YearsYoji Murakami, Takahiro Yamaguchi, Masato Goya, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Annals of Surgical Oncology|February 14, 2024
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical ProstatectomyMasaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, et al.
Cancer Science|April 29, 2022
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancerMasaki Shiota, Dai Takamatsu, Takahiro Kimura, et al.
Cancer Science|June 19, 2021
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura, et al.
Cancer Science|November 7, 2020
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Japanese Journal of Clinical Oncology|April 30, 2026
Impact of treatment volume on outcomes for patients with penile cancer at relatively low-volume centers in JapanYoji Murakami, Takahiro Yamaguchi, Masato Goya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 11, 2025
Penile Cancer: Differences Between Patients Over and Under the Age of 75 YearsYoji Murakami, Takahiro Yamaguchi, Masato Goya, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Annals of Surgical Oncology|February 14, 2024
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical ProstatectomyMasaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, et al.
Cancer Science|April 29, 2022
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancerMasaki Shiota, Dai Takamatsu, Takahiro Kimura, et al.
Cancer Science|June 19, 2021
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura, et al.
Cancer Science|November 7, 2020
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito, et al.
Pageof 18